Private Equity Firm Profile
In the last 3 years, Aisling Capital has acquired 1 company. It has also invested in 1 other.
Aisling Capital’s most common sectors for investment arelife science (75%) and medical products (13%) . The Firm’s most common investment types include venture (52%) and pipe (22%). In total, Aisling Capital has invested in 14 US states and 5 different countries. Its largest (disclosed) acquisition occurred in 2007 when it acquired Catalent for $3.3B.
In the last 3 years, Aisling Capital has exited 5 companies. The Firm’s most common exit type is trade sale (59%). Aisling Capital’s largest (disclosed) exit occurred in 2017 when it sold ZELTIQ Aesthetics for $2.5B.
Join Mergr to view Aisling Capital’s full profile and discover more large private equity firm investors just like it.
M&A Summary
-
M&A Total Activity96
- M&A Buy Activity56
- M&A Sell Activity40
- Total Sectors Invested 6
- Total Countries Invested 5
- M&A Buy/Sell Connections 32
- M&A Advisors 3
Unlimited Searches
